Next week, as part of the VIZBI 2018 session on DNA, Marcin Imielinski from New York Genome Centre (USA), will speak about structural DNA variants that drive cancer progression and render tumors sensitive to drugs. A key obstacle for understanding is difficulty in seeing beyond shreds of sequence in our genome. Marcin will review state of the art approaches in understanding, introducing the paradigm of a cancer graph genome to detect recurrent mutational signatures. Further information on Marcin’s talk is available at https://vizbi.org/Talks/Marcin_Imielinski.
